Enhabit Inc (NYSE: EHAB) stock jumped 1.34% on Friday to $9.82 against a previous-day closing price of $9.69. With 0.62 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.71 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $9.99 whereas the lowest price it dropped to was $9.59. The 52-week range on EHAB shows that it touched its highest point at $16.64 and its lowest point at $7.12 during that stretch. It currently has a 1-year price target of $10.25. Beta for the stock currently stands at 1.21.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EHAB was up-trending over the past week, with a rise of 5.59%, but this was up by 20.20% over a month. Three-month performance dropped to -16.43% while six-month performance fell -17.41%. The stock lost -19.90% in the past year, while it has lost -25.38% so far this year. A look at the trailing 12-month EPS for EHAB yields -1.33 with Next year EPS estimates of 0.24. For the next quarter, that number is 0.03. This implies an EPS growth rate of -87.88% for this year and 30.46% for next year.
Float and Shares Shorts:
At present, 50.10 million EHAB shares are outstanding with a float of 44.13 million shares on hand for trading. On Oct 30, 2023, short shares totaled 4.78 million, which was 9.54% higher than short shares on Sep 28, 2023. In addition to Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. as the firm’s President, CEO & Director, Ms. Crissy Buchanan Carlisle serves as its Executive VP & CFO.
Other institutions hold 60.38% of EHAB, in contrast to 53.16% held by mutual funds. Shares owned by individuals account for 1.69%. As the largest shareholder in EHAB with 14.49% of the stake, BlackRock Fund Advisors holds 7,259,721 shares worth 7,259,721. A second-largest stockholder of EHAB, The Vanguard Group, Inc., holds 5,646,286 shares, controlling over 11.27% of the firm’s shares. JANA Partners LLC is the third largest shareholder in EHAB, holding 2,474,398 shares or 4.94% stake. With a 6.75% stake in EHAB, the iShares Core S&P Small Cap ETF is the largest stakeholder. A total of 3,382,279 shares are owned by the mutual fund manager. The Janus Henderson Small Cap Value F, which owns about 3.30% of EHAB stock, is the second-largest Mutual Fund holder. It holds 1,651,390 shares valued at 12.17 million. Vanguard Total Stock Market ETF holds 3.08% of the stake in EHAB, owning 1,542,041 shares worth 11.36 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for EHAB since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With EHAB analysts setting a high price target of $15.00 and a low target of $8.00, the average target price over the next 12 months is $10.25. Based on these targets, EHAB could surge 52.75% to reach the target high and fall by -18.53% to reach the target low. Reaching the average price target will result in a growth of 4.38% from current levels.
Summary of Insider Activity:
Insiders traded EHAB stock several times over the past three months with 0 Buys and 1 Sells. In these transactions, 0 shares were bought while 1,636 shares were sold. The number of buy transactions has increased to 36 while that of sell transactions has risen to 20 over the past year. The total number of shares bought during that period was 311,125 while 20,403 shares were sold.